NET PROFIT (x1000 SEK)
EMPLOYEES
Pharmalundensis AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
513
|
459
|
411 |
| Earnings before taxes |
-4,400
|
-3,286
|
-2,609 |
| EBITDA |
-2,859
|
-2,615
|
-2,198 |
| Total assets |
10,963
|
8,760
|
8,309 |
| Current assets |
2,794
|
621
|
1,135 |
| Current liabilities |
2,653
|
2,366
|
932 |
| Equity capital |
3,159
|
1,756
|
3,198 |
| - share capital |
2,110
|
1,489
|
1,388 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
28.8%
|
20.0%
|
38.5% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-35.5%
|
-32.3%
|
-26.5% |
| Current ratio |
105.3%
|
26.2%
|
121.8% |
| Return on equity (ROE) |
-139.3%
|
-187.1%
|
-81.6% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.